Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 11 04:00PM ET
6.30
Dollar change
-0.01
Percentage change
-0.16
%
IndexRUT P/E- EPS (ttm)-5.58 Insider Own17.68% Shs Outstand60.04M Perf Week8.43%
Market Cap385.39M Forward P/E- EPS next Y-4.06 Insider Trans0.00% Shs Float50.36M Perf Month-4.40%
Income-337.59M PEG- EPS next Q-1.52 Inst Own85.99% Short Float12.13% Perf Quarter-22.60%
Sales106.40M P/S3.62 EPS this Y28.43% Inst Trans-5.76% Short Ratio9.19 Perf Half Y-48.21%
Book/sh9.02 P/B0.70 EPS next Y37.31% ROA-42.95% Short Interest6.11M Perf Year-63.46%
Cash/sh9.33 P/C0.68 EPS next 5Y16.80% ROE-49.34% 52W Range5.64 - 28.26 Perf YTD-70.93%
Dividend Est.- P/FCF- EPS past 5Y-2.28% ROI-60.07% 52W High-77.71% Beta0.91
Dividend TTM- Quick Ratio10.02 Sales past 5Y3395.58% Gross Margin91.75% 52W Low11.70% ATR (14)0.49
Dividend Ex-Date- Current Ratio10.02 EPS Y/Y TTM49.20% Oper. Margin-349.50% RSI (14)41.06 Volatility6.61% 7.13%
Employees487 Debt/Eq0.02 Sales Y/Y TTM837.52% Profit Margin-317.29% Recom2.95 Target Price10.00
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q54.52% Payout- Rel Volume0.78 Prev Close6.31
Sales Surprise9.93% EPS Surprise0.80% Sales Q/Q337.08% EarningsOct 29 AMC Avg Volume664.93K Price6.30
SMA20-10.05% SMA50-11.74% SMA200-50.64% Trades Volume518,428 Change-0.16%
Date Action Analyst Rating Change Price Target Change
Oct-10-24Resumed Raymond James Mkt Perform
Oct-04-24Downgrade RBC Capital Mkts Outperform → Sector Perform $10 → $4
Jul-30-24Downgrade TD Cowen Buy → Hold $16 → $10
Jul-25-24Downgrade JP Morgan Overweight → Neutral $18 → $12
May-29-24Initiated Robert W. Baird Neutral $15
May-29-24Initiated Citigroup Sell $8
Apr-17-24Downgrade BofA Securities Neutral → Underperform $24 → $14
Dec-12-23Initiated Deutsche Bank Hold $21
Aug-08-23Downgrade Needham Buy → Hold
Aug-08-23Downgrade Goldman Buy → Neutral $22
Oct-31-24 07:39AM
Oct-30-24 07:38AM
03:13AM
Oct-29-24 05:20PM
04:05PM
10:10AM Loading…
Oct-28-24 10:10AM
Oct-23-24 10:00AM
05:45AM
Oct-22-24 10:01AM
Oct-18-24 03:02PM
Oct-17-24 03:56PM
12:32PM
10:16AM
10:11AM
09:47AM
08:08AM Loading…
08:08AM
07:00AM
Oct-15-24 06:30AM
Oct-10-24 08:46AM
Oct-08-24 10:53AM
09:19AM
08:52AM
08:21AM
07:36AM
07:06AM
06:30AM
Oct-04-24 09:14AM
Sep-29-24 07:54AM
Sep-27-24 07:28AM
Sep-26-24 10:37AM
07:00AM Loading…
07:00AM
Sep-25-24 11:34AM
Sep-24-24 05:45AM
Sep-10-24 05:45AM
Sep-05-24 08:30AM
Aug-30-24 11:31AM
Aug-08-24 10:00AM
Aug-01-24 11:27AM
Jul-31-24 05:20PM
04:05PM
Jul-25-24 04:52AM
Jul-24-24 04:07PM
10:34AM
10:01AM
08:10AM
06:30AM
Jul-22-24 01:12AM
Jul-17-24 06:30AM
Jun-11-24 06:30AM
Jun-05-24 06:30AM
May-29-24 12:12PM
09:52AM
May-13-24 07:57PM
May-07-24 06:30AM
Apr-30-24 12:57PM
Apr-26-24 11:27AM
Apr-25-24 02:33PM
10:54AM
08:04AM
07:35AM
06:30AM
Apr-18-24 11:37AM
10:01AM
Apr-17-24 04:10PM
02:41PM
08:46AM
07:44AM
06:39AM
06:30AM
Apr-11-24 07:29PM
06:30AM
Apr-10-24 06:09PM
07:47AM
Mar-18-24 10:16AM
Mar-15-24 11:30AM
Feb-28-24 06:30AM
Feb-15-24 01:36PM
10:50AM
Feb-14-24 07:15AM
06:42AM
06:30AM
Feb-07-24 10:00AM
Jan-31-24 06:30AM
Jan-08-24 06:32AM
06:30AM
Jan-02-24 06:30AM
Dec-20-23 02:15PM
Dec-14-23 06:30AM
Dec-07-23 11:31AM
Nov-13-23 11:13AM
Nov-08-23 01:11PM
07:59AM
06:30AM
Nov-07-23 06:02PM
05:41PM
12:40PM
08:44AM
07:40AM
07:21AM
06:30AM
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. Its products include ZURZUVAE and ZULRESSO. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
IGUCHI KIMICFO & TreasurerJan 02 '24Option Exercise1.361,6422,23370,429Jan 04 04:07 PM